单次立体定向放射外科与海马保护全脑放疗在10–30个脑转移瘤中的剂量学比较
本研究回顾性分析10例10个以上脑转移瘤患者的放疗计划,比较海马保护全脑放疗(HA-WBRT)与单次立体定向放射外科(SRS)及一种新型分区自适应放射外科(SPARE)策略的剂量学差异。结果显示,SRS策略在海马和正常脑组织剂量上均显著优于HA-WBRT,且SPARE进一步降低所有剂量指标。
要点
- SPARE策略将多发转移瘤的单次SRS分配至连续多日,每日治疗时间≤60分钟。
- 与HA-WBRT相比,SPARE使海马最大点剂量、平均剂量和D40%分别降低86%、93%和93%。
核心结论
- 伽玛刀(GKI)在海马和正常脑组织剂量学上优于HA-WBRT,SPARE策略进一步带来剂量学优势。
研究设计与样本
- 回顾性分析10例10个以上脑转移瘤(距海马>5 mm)的SRS治疗计划,比较GKI-SPARE、单日单次GKI和30 Gy/10次HA-WBRT的剂量学。
主要发现
- 与HA-WBRT相比,GKI-SPARE使海马最大点剂量、平均剂量和D40%的中位2 Gy分次等效剂量分别降低86%、93%和93%,GKI-SFR分别降低81%、92%和91%。
- 正常脑中位平均剂量在GKI-SPARE和GKI-SFR中分别降低95%和94%。
关键数值与推荐
- GKI-SPARE每日治疗时间限制在≤60分钟,分区于连续多日完成单次SRS。
- 剂量指标转换为2 Gy分次等效剂量进行比较。
临床怎么用
- 对于10–30个脑转移瘤患者,可考虑采用GKI-SPARE或GKI-SFR以降低海马和正常脑剂量,SPARE可能进一步减少毒性。
局限性
- 回顾性设计,样本量仅10例,剂量学终点而非临床结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare normal tissue dosimetry between hippocampal-avoidance whole brain radiation therapy (HA-WBRT) and stereotactic radiosurgery (SRS) in patients with 10 to 30 brain metastases, and to describe a novel SRS strategy we term Spatially Partitioned Adaptive RadiosurgEry (SPARE). METHODS AND MATERIALS: A retrospective review identified SRS treatment plans with >10 brain metastases located >5 mm from the hippocampi. Our Gamma Knife Icon (GKI) SPARE (GKI-Spr) technique treats multiple metastases with single-fraction SRS partitioned over consecutive days while limiting the total treatment time to ≤60 minutes per day. Hippocampal and normal brain dosimetry were compared among GKI-Spr, single-fraction single-day GKI (GKI-Sfr), and 30 Gy in 10 fractions HA-WBRT. Dose metrics were converted to equivalent dose in 2 Gy fractions. RESULTS: Ten cases were analyzed. Compared with HA-WBRT, GKI-Spr significantly reduced the median equivalent dose in 2 Gy fractions hippocampal maximum point dose, mean dose, and dose to 40% of the hippocampi (D40%) by 86%, 93%, and 93%, respectively, and similarly for GKI-Sfr by 81%, 92%, and 91%, respectively. The normal brain median mean dose was reduced by 95% with GKI-Spr and 94% with GKI-Sfr. Compared with GKI-Sfr, GKI-Spr further reduced all normal brain and hippocampal dose metrics (P ≤ .014). CONCLUSIONS: GKI yields superior hippocampal and normal brain dosimetry compared with HA-WBRT, and GKI-Spr results in further dosimetric advantages.
引用
- Nguyen TK, Sahgal A, Detsky J, et al. Single-Fraction Stereotactic Radiosurgery Versus Hippocampal-Avoidance Whole Brain Radiation Therapy for Patients With 10 to 30 Brain Metastases: A Dosimetric Analysis. Int J Radiat Oncol Biol Phys. 2019. PMID: 31283978. doi:10.1016/j.ijrobp.2019.06.2543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。